{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T09:57:58Z","timestamp":1760781478070},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.ejphar.2005.02.044","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T11:24:43Z","timestamp":1113564283000},"page":"243-248","source":"Crossref","is-referenced-by-count":15,"title":["Effects of oleoyl-estrone with dexfenfluramine, sibutramine or phentermine on overweight rats"],"prefix":"10.1016","volume":"513","author":[{"given":"Raquel","family":"Ferrer-Lorente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Cabot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9-Antonio","family":"Fern\u00e1ndez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Remesar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari\u00e0","family":"Alemany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2005.02.044_bib1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/sj.ijo.0800828","article-title":"Oleoyl-estrone treatment affects the ponderostat setting differently in lean and obese Zucker rats","volume":"22","author":"Ad\u00e1n","year":"1999","journal-title":"Int. J. Obesity"},{"key":"10.1016\/j.ejphar.2005.02.044_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1157\/13053142","article-title":"P\u00e9rdida de peso en un paciente con obesidad m\u00f3rbida en tratamiento con oleoil-estrona (Weight loss in a patient with morbid obesity under treatment with oleoyl-estrone)","volume":"121","author":"Alemany","year":"2003","journal-title":"Med. Clin."},{"key":"10.1016\/j.ejphar.2005.02.044_bib3","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/ajcn\/34.12.2763","article-title":"The contribution of increased thermogenesis to the effect of anorectic drugs on body composition in mice","volume":"34","author":"Arch","year":"1981","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ejphar.2005.02.044_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1076\/apab.105.5.487.3295","article-title":"Effect of the slimming agent oleoyl-estrone in liposomes (Merlin-2) on the body weight of rats fed a cafeteria diet","volume":"105","author":"Balada","year":"1997","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2005.02.044_bib5","first-page":"491","article-title":"Body-composition of obese rats fed the anorectic drug dexfenfluramine","volume":"33","author":"Beynen","year":"1986","journal-title":"Nutr. Rep. Int."},{"key":"10.1016\/j.ejphar.2005.02.044_bib6","first-page":"S51","article-title":"Dexfenfluramine and appetite in humans","volume":"16","author":"Blundell","year":"1992","journal-title":"Int. J. Obesity"},{"key":"10.1016\/j.ejphar.2005.02.044_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diacare.23.1.57","article-title":"Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity","volume":"23","author":"Bonora","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2005.02.044_bib8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1210\/er.20.6.805","article-title":"Current and potential drugs for treatment of obesity","volume":"20","author":"Bray","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2005.02.044_bib9","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0196-9781(98)00104-1","article-title":"Oleoyl-estrone does not alter hypothalamic neuropeptide Y","volume":"19","author":"Cabot","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2005.02.044_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0361-9230(98)00050-1","article-title":"Zucker obese rats are insensitive to the CRH-increasing effect of oleoyl-estrone","volume":"46","author":"Cabot","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2005.02.044_bib11","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2165\/00003495-200262060-00005","article-title":"Pharmacological approaches for the treatment of obesity","volume":"62","author":"Fern\u00e1ndez-L\u00f3pez","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2005.02.044_bib12","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/sj.ijo.0802216","article-title":"Sibutramine: its mode of action and efficacy","volume":"26","author":"Finer","year":"2002","journal-title":"Int. J. Obesity"},{"key":"10.1016\/j.ejphar.2005.02.044_bib13","first-page":"598","article-title":"Prolonged weight-loss with dexfenfluramine treatment in obese patients","volume":"13","author":"Finer","year":"1987","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ejphar.2005.02.044_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipids from animal tissues","volume":"232","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2005.02.044_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/oby.2001.22","article-title":"Daily oral oleoyl-estrone gavage induces a dose-dependent loss of fat in Wistar rats","volume":"9","author":"Grasa","year":"2001","journal-title":"Obes. Res."},{"key":"10.1016\/j.ejphar.2005.02.044_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1463-1326.2001.00143.x","article-title":"Oral gavage of oleoyl-estrone has a stronger effect on body weight in male obese Zucker rats than in female","volume":"3","author":"Grasa","year":"2001","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2005.02.044_bib17","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.ijo.0801059","article-title":"The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction","volume":"23","author":"Hansen","year":"1999","journal-title":"Int. J. Obesity"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2005.02.044_bib18","first-page":"S18","article-title":"Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine","volume":"22","author":"Heal","year":"1998","journal-title":"Int. J. Obesity"},{"key":"10.1016\/j.ejphar.2005.02.044_bib19","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","article-title":"Effect of sibutramine on weight maintenance after weight loss: a randomised trial","volume":"356","author":"James","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2005.02.044_bib20","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/01.CIR.101.17.2071","article-title":"Fenfluramine and phentermine and cardiovascular findings-effect of treatment duration on prevalence of valve abnormalities","volume":"101","author":"Jollis","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2005.02.044_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1467-789X.2003.00083.x","article-title":"Treatment of obesity: an update on anti-obesity medications","volume":"4","author":"Mancini","year":"2003","journal-title":"Obes. Rev."},{"key":"10.1016\/j.ejphar.2005.02.044_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and B cell function from fasting plasma glucose and insulin concentration in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2005.02.044_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM195307022490104","article-title":"Glucostatic mechanism of regulation of food intake","volume":"249","author":"Mayer","year":"1953","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2005.02.044_bib24","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.ijo.0802056","article-title":"Effect of oral oleoyl-estrone on adipose tissue composition in male rats","volume":"26","author":"Remesar","year":"2002","journal-title":"Int. J. Obesity"},{"key":"10.1016\/j.ejphar.2005.02.044_bib25","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.amjcard.2003.08.034","article-title":"Comparison of survival in patients with pulmonary hypertension associated with fenfluramine to patients with primary pulmonary hypertension","volume":"92","author":"Rich","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2005.02.044_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1358\/dot.2004.40.1.799437","article-title":"Clinical use of sibutramine","volume":"40","author":"Ryan","year":"2004","journal-title":"Drugs Today"},{"key":"10.1016\/j.ejphar.2005.02.044_bib27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1067\/mhj.2002.126733","article-title":"Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies","volume":"144","author":"Sachdev","year":"2002","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2005.02.044_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0773.1993.tb01537.x","article-title":"Neurochemical mechanism of action of anorectic drugs","volume":"73","author":"Samanin","year":"1993","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2005.02.044_bib29","first-page":"588","article-title":"Oleoyl-estrone induces the loss of body fat in rats","volume":"20","author":"Sanchis","year":"1990","journal-title":"Int. J. Obesity"},{"key":"10.1016\/j.ejphar.2005.02.044_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00003495-199000393-00007","article-title":"Dexfenfluramine. Its place in weight control","volume":"39","author":"Turner","year":"1990","journal-title":"Drugs"},{"issue":"suppl. 1","key":"10.1016\/j.ejphar.2005.02.044_bib31","first-page":"S38","article-title":"Sibutramine and fat distribution: is there a role for pharmacotherapy in abdominal\/visceral fat reduction?","volume":"22","author":"van Gaal","year":"1998","journal-title":"Int J. Obesity"},{"key":"10.1016\/j.ejphar.2005.02.044_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0091-3057(01)00763-8","article-title":"Role of 5-HT1A receptors in the control of food intake in obese Zucker rats of different ages","volume":"72","author":"Voigt","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2005.02.044_bib33","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.ijo.0800920","article-title":"Synergistic interactions between fenfluramine and phentermine","volume":"23","author":"Wellman","year":"1999","journal-title":"Int. J. Obesity"},{"key":"10.1016\/j.ejphar.2005.02.044_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0378-4274(84)90056-0","article-title":"Alterations in monoamine oxidase activity after single and repeated exposure of rats to chlorphenthermine","volume":"22","author":"Zychlinski","year":"1984","journal-title":"Toxicol. Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905002396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905002396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T20:35:27Z","timestamp":1625776527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299905002396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0014299905002396"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2005.02.044","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}